ATE509018T1 - Als antimikrobielle mittel geeignete bisindolpyrrole - Google Patents

Als antimikrobielle mittel geeignete bisindolpyrrole

Info

Publication number
ATE509018T1
ATE509018T1 AT05726272T AT05726272T ATE509018T1 AT E509018 T1 ATE509018 T1 AT E509018T1 AT 05726272 T AT05726272 T AT 05726272T AT 05726272 T AT05726272 T AT 05726272T AT E509018 T1 ATE509018 T1 AT E509018T1
Authority
AT
Austria
Prior art keywords
disclosed
compounds
bisindolpyrroles
antimicrobial agent
bis
Prior art date
Application number
AT05726272T
Other languages
English (en)
Inventor
Scott S Mitchell
Kin S Lam
Barbara C Potts
Ginger Tsueng
Jennifer Grodberg
Donald J White
Katherine Anne Reed
Original Assignee
Nereus Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nereus Pharmaceuticals Inc filed Critical Nereus Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE509018T1 publication Critical patent/ATE509018T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT05726272T 2004-01-23 2005-01-21 Als antimikrobielle mittel geeignete bisindolpyrrole ATE509018T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53905304P 2004-01-23 2004-01-23
US62723504P 2004-11-12 2004-11-12
PCT/US2005/002039 WO2005070922A2 (en) 2004-01-23 2005-01-21 Bis-indole pyrroles useful as antimicrobials agents

Publications (1)

Publication Number Publication Date
ATE509018T1 true ATE509018T1 (de) 2011-05-15

Family

ID=34811361

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05726272T ATE509018T1 (de) 2004-01-23 2005-01-21 Als antimikrobielle mittel geeignete bisindolpyrrole

Country Status (9)

Country Link
US (2) US7166634B2 (de)
EP (1) EP1711486B1 (de)
JP (1) JP2007519727A (de)
KR (1) KR20060132698A (de)
AT (1) ATE509018T1 (de)
AU (1) AU2005206560A1 (de)
BR (1) BRPI0506535A (de)
CA (1) CA2552350A1 (de)
WO (1) WO2005070922A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005070922A2 (en) 2004-01-23 2005-08-04 Nereus Pharmaceuticals, Inc. Bis-indole pyrroles useful as antimicrobials agents
WO2010096719A2 (en) * 2009-02-19 2010-08-26 The Uab Research Foundation Anticancer and antimicrobial compounds from antarctic extremophilic microorganisms
US20110008469A1 (en) * 2009-07-09 2011-01-13 Florida Gulf Coast University Antimicrobial composition and methods and apparatus for use thereof
WO2013040528A1 (en) * 2011-09-16 2013-03-21 Microbiotix, Inc. Antimicrobial compounds
WO2013040526A1 (en) * 2011-09-16 2013-03-21 Microbiotix, Inc. Antimicrobial compounds
WO2013040527A1 (en) * 2011-09-16 2013-03-21 Microbiotix, Inc. Antimicrobial compounds
US20150291565A1 (en) * 2012-11-13 2015-10-15 Memorial Sloan-Kettering Cancer Center Indole compounds and their use as antimicrobials
EP3301096A1 (de) * 2016-09-30 2018-04-04 Heinrich-Heine-Universität Düsseldorf Bis-indole abkömmlinge zur behandlung bakterieller infektionen

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5133974A (en) 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US4970226A (en) 1989-10-03 1990-11-13 Harbor Branch Oceanographic Institution, Inc. Bis-indole imidazole compounds which are useful antitumor and antimicrobial agents
US5276182A (en) 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers
DE4039602A1 (de) 1990-12-12 1992-06-17 Bauer Kurt Heinz Prof Dr Pharmazeutische formulierungen
KR100221695B1 (ko) 1991-08-12 1999-09-15 그린 마틴, 브라이언 쥐 테슬리 약학적 구상 제형
US5653962A (en) 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
CA2149150C (en) 1992-11-27 2000-08-01 David R. Carver Injectable taxol composition with improved stability
JPH06247964A (ja) 1993-02-22 1994-09-06 Snow Brand Milk Prod Co Ltd 新規生理活性物質ｈｓ−１及びその製造方法
US5654286A (en) 1993-05-12 1997-08-05 Hostetler; Karl Y. Nucleotides for topical treatment of psoriasis, and methods for using same
CZ301771B6 (cs) 1993-10-01 2010-06-16 Syntex (U.S.A.) Llc. Farmaceutický prostredek ve forme suchého granulátu obsahující mofetil mykofenolát nebo kyselinu mykofenolovou a zpusob jeho prípravy
US5707641A (en) 1994-10-13 1998-01-13 Pharmaderm Research & Development Ltd. Formulations comprising therapeutically-active proteins or polypeptides
IE80468B1 (en) 1995-04-04 1998-07-29 Elan Corp Plc Controlled release biodegradable nanoparticles containing insulin
US5653987A (en) 1995-05-16 1997-08-05 Modi; Pankaj Liquid formulations for proteinic pharmaceuticals
US5726181A (en) 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
US5667809A (en) 1995-06-07 1997-09-16 Alliance Pharmaceutical Corp. Continuous fluorochemical microdispersions for the delivery of lipophilic pharmaceutical agents
US5874443A (en) 1995-10-19 1999-02-23 Trega Biosciences, Inc. Isoquinoline derivatives and isoquinoline combinatorial libraries
US5886210A (en) 1996-08-22 1999-03-23 Rohm And Haas Company Method for preparing aromatic compounds
US5922683A (en) 1997-05-29 1999-07-13 Abbott Laboratories Multicyclic erythromycin derivatives
DE69842004D1 (de) 1997-11-21 2010-12-30 Purdue Neuroscience Co Substituierte 2-aminoacetamide und anwendung davon
WO1999042100A1 (en) 1998-02-23 1999-08-26 Sagami Chemical Research Center Cell death inhibitors
CN1142909C (zh) 1998-03-26 2004-03-24 盐野义制药株式会社 具有抗病毒活性的吲哚衍生物
US6509331B1 (en) 1998-06-22 2003-01-21 Elan Pharmaceuticals, Inc. Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
FR2784988B1 (fr) 1998-10-23 2002-09-20 Adir Nouveaux composes dihydro et tetrahydroquinoleiniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU2039800A (en) 1998-12-04 2000-06-26 Ontogen Corporation 5-membered heterocycles for the treatment of human diseases involving modulatorsof selectins
WO2000047575A1 (en) * 1999-02-09 2000-08-17 Sagami Chemical Research Center Pyrrole derivatives and cell death inhibitors
US6569830B1 (en) * 1999-03-05 2003-05-27 Ambi, Inc. Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains
WO2002055725A2 (en) 2000-11-14 2002-07-18 Phibro-Tech, Inc., Doing Business As Agtrol International Novel nucleic acids, methods and transformed cells for the modulation of gibberellin production
EP1352906A4 (de) 2001-01-18 2004-06-16 Sankyo Co Zusammensetzungen für die prävention bzw. behandlung von lebererkrankungen
DE10109280A1 (de) 2001-02-26 2002-09-05 Peter Mayser Indolderivate mit inhibitorischer Wirkung auf Proteinkinasen
WO2005070922A2 (en) 2004-01-23 2005-08-04 Nereus Pharmaceuticals, Inc. Bis-indole pyrroles useful as antimicrobials agents

Also Published As

Publication number Publication date
WO2005070922A3 (en) 2005-09-09
KR20060132698A (ko) 2006-12-21
JP2007519727A (ja) 2007-07-19
CA2552350A1 (en) 2005-08-04
US7166634B2 (en) 2007-01-23
US7375129B2 (en) 2008-05-20
WO2005070922A2 (en) 2005-08-04
EP1711486A2 (de) 2006-10-18
BRPI0506535A (pt) 2007-02-27
AU2005206560A1 (en) 2005-08-04
EP1711486B1 (de) 2011-05-11
US20070149601A1 (en) 2007-06-28
US20050267192A1 (en) 2005-12-01

Similar Documents

Publication Publication Date Title
TW200718422A (en) 1,6-Dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same
TW200714604A (en) Substituted heterocycles and the uses thereof
ATE433980T1 (de) Gyraseinhibitoren und deren verwendungen
EA200801291A1 (ru) Карбониламинопирролопиразолы в качестве эффективных ингибиторов киназ
ATE433447T1 (de) Pyrimiidinverbindungen
EA200600280A1 (ru) Композиции на основе производных липопептидных антибиотиков и способы их применения
TW200517381A (en) Bicyclic heteroaryl derivatives
BRPI0510177B8 (pt) composto, composição farmacêutica e uso do mesmo
EA201100450A1 (ru) Макроциклические пирамидины в качестве ингибиторов протеинкиназы
WO2006028525A3 (en) [3.2.0] heterocyclic compounds and methods of using the same
BRPI0410913A (pt) benzotiofenos substituìdos com cicloalquil e heterocicloalquil como agentes terapêuticos
TNSN07240A1 (en) Compounds for flaviviridae treatment
UY30030A1 (es) Derivados sustituidos de la 8-piracin-2-il-1,2,4,4a-tetrahidro-2´h, 6h-espiro (1,4-oxacin(4,3-a)quinolin-5,5´-pirimidin)-2´, 4´, 6´ (1´h, 3´h)-tiona, composiciones y aplicaciones
WO2007067559A3 (en) Antibacterial agents
NZ545472A (en) 7-(4-substituted-3-cyclopropylaminomethyl-1-pyrrolidinyl)quinolonecarboxylic acid derivative
EA200701930A1 (ru) Производные пиримидина для лечения гиперпролиферативных нарушений
TW200630367A (en) Substituted adenines and the uses thereof
CL2004000979A1 (es) Nonapeptidos acilados tipo lysobacitina, composicion que los contiene metodo de preparacion, util como bactericida.
WO2006120563A3 (en) Antibacterial agents
ATE509018T1 (de) Als antimikrobielle mittel geeignete bisindolpyrrole
WO2007066336A3 (en) Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof
WO2005011609A3 (en) Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
UY28542A1 (es) Amidas macrocíclicas antibacterianas
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
ECSP066484A (es) Compuestos y metodos para el tratamiento de dislipidemia

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties